Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 252

1.

Human leukocyte antigen-associated HIV-1 CRF02_AG gag and vif polymorphisms in Ghana.

Adusei-Poku MA, Matsuoka S, Bonney EY, Abana CZ, Duker EO, Nii-Trebi NI, Ofori SB, Mizutani T, Ishizaka A, Shiino T, Kawana-Tachikawa A, Ishikawa K, Ampofo WK, Matano T.

Jpn J Infect Dis. 2019 Jun 28. doi: 10.7883/yoken.JJID.2019.201. [Epub ahead of print]

2.

Evaluation of a Novel Immunochromatographic Assay for Detection of Human Adenoviruses from Throat Swab Samples Compared with Real-time PCR.

Ishiguro N, Kaiho M, Kikuta H, Togashi T, Sato D, Yasoshima K, Akutsu Y, Yamanaka T, Nagano N, Ishizaka A, Okamura A, Kumita Y, Nagano H, Okano M, Ariga T.

Clin Lab. 2018 Oct 1;64(10):1777-1781. doi: 10.7754/Clin.Lab.2018.180420.

PMID:
30336514
3.

Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014-2015 to 2016-2017 influenza seasons in Japan.

Ishiguro N, Koseki N, Kaiho M, Ariga T, Kikuta H, Oba K, Togashi T, Morita K, Inagawa A, Okamura A, Yamazaki S, Shida S, Konno M, Kawamura N, Ishizaka A, Takada K, Tsubakihara K, Nagano N, Shibata M, Furuyama H, Matsuzono Y, Koike A, Murashita M, Hatae Y, Arioka H, Yamanaka T, Watanabe T, Tabata Y, Kumita Y, Hazama K, Akutsu Y, Aoyagi H, Tobise C, Azuma K, Yasoshima K, Sawada Y, Uetsuji K, Tsuchida A, Tsuchiyama A, Yasuda K, Odagawa Y, Yoshioka M.

J Infect Chemother. 2018 Jun;24(6):449-457. doi: 10.1016/j.jiac.2018.01.013. Epub 2018 Feb 24.

4.

Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.

Ishiguro N, Koseki N, Kaiho M, Ariga T, Kikuta H, Togashi T, Oba K, Morita K, Nagano N, Nakanishi M, Hara K, Hazama K, Watanabe T, Yamanaka T, Sasaki S, Furuyama H, Shibata M, Shida S, Ishizaka A, Tabata Y, Aoyagi H, Naito H, Yoshioka M, Horino A, Kenri T; Hokkaido Pediatric Respiratory Infection Study Group.

PLoS One. 2017 Mar 13;12(3):e0173635. doi: 10.1371/journal.pone.0173635. eCollection 2017.

5.

Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy.

Ishizaka A, Sato H, Nakamura H, Koga M, Kikuchi T, Hosoya N, Koibuchi T, Nomoto A, Kawana-Tachikawa A, Mizutani T.

J Virol. 2016 May 27;90(12):5665-5676. doi: 10.1128/JVI.03158-15. Print 2016 Jun 15.

6.

Transferrin Receptor 1 Facilitates Poliovirus Permeation of Mouse Brain Capillary Endothelial Cells.

Mizutani T, Ishizaka A, Nihei C.

J Biol Chem. 2016 Feb 5;291(6):2829-36. doi: 10.1074/jbc.M115.690941. Epub 2015 Dec 4.

7.

Acquired resistance to decitabine and cross-resistance to gemcitabine during the long-term treatment of human HCT116 colorectal cancer cells with decitabine.

Hosokawa M, Saito M, Nakano A, Iwashita S, Ishizaka A, Ueda K, Iwakawa S.

Oncol Lett. 2015 Aug;10(2):761-767. Epub 2015 May 22.

8.

The Werner Protein Acts as a Coactivator of Nuclear Factor κB (NF-κB) on HIV-1 and Interleukin-8 (IL-8) Promoters.

Mizutani T, Ishizaka A, Furuichi Y.

J Biol Chem. 2015 Jul 24;290(30):18391-9. doi: 10.1074/jbc.M115.657155. Epub 2015 Jun 2.

9.

The miR-199a/Brm/EGR1 axis is a determinant of anchorage-independent growth in epithelial tumor cell lines.

Kobayashi K, Sakurai K, Hiramatsu H, Inada K, Shiogama K, Nakamura S, Suemasa F, Kobayashi K, Imoto S, Haraguchi T, Ito H, Ishizaka A, Tsutsumi Y, Iba H.

Sci Rep. 2015 Feb 12;5:8428. doi: 10.1038/srep08428.

10.

7SK small nuclear ribonucleoprotein complex is recruited to the HIV-1 promoter via short viral transcripts.

Mizutani T, Ishizaka A, Suzuki Y, Iba H.

FEBS Lett. 2014 May 2;588(9):1630-6. doi: 10.1016/j.febslet.2014.01.067. Epub 2014 Mar 6.

11.

Ethanol-induced hyponatremia augments brain edema after traumatic brain injury.

Katada R, Watanabe S, Ishizaka A, Mizuo K, Okazaki S, Matsumoto H.

Nihon Arukoru Yakubutsu Igakkai Zasshi. 2012 Apr;47(2):68-74.

PMID:
22746038
12.

Prediction of requirement for mechanical ventilation in community-acquired pneumonia with acute respiratory failure: a multicenter prospective study.

Kohno S, Seki M, Takehara K, Yamada Y, Kubo K, Ishizaka A, Soma K.

Respiration. 2013;85(1):27-35. doi: 10.1159/000335466. Epub 2012 Feb 14.

13.

Double plant homeodomain (PHD) finger proteins DPF3a and -3b are required as transcriptional co-activators in SWI/SNF complex-dependent activation of NF-κB RelA/p50 heterodimer.

Ishizaka A, Mizutani T, Kobayashi K, Tando T, Sakurai K, Fujiwara T, Iba H.

J Biol Chem. 2012 Apr 6;287(15):11924-33. doi: 10.1074/jbc.M111.322792. Epub 2012 Feb 13.

14.

Induction of mucin and MUC5AC expression by the protease activity of Aspergillus fumigatus in airway epithelial cells.

Oguma T, Asano K, Tomomatsu K, Kodama M, Fukunaga K, Shiomi T, Ohmori N, Ueda S, Takihara T, Shiraishi Y, Sayama K, Kagawa S, Natori Y, Lilly CM, Satoh K, Makimura K, Ishizaka A.

J Immunol. 2011 Jul 15;187(2):999-1005. doi: 10.4049/jimmunol.1002257. Epub 2011 Jun 17.

15.

Gradual increase of high mobility group protein b1 in the lungs after the onset of acute exacerbation of idiopathic pulmonary fibrosis.

Ebina M, Taniguchi H, Miyasho T, Yamada S, Shibata N, Ohta H, Hisata S, Ohkouchi S, Tamada T, Nishimura H, Ishizaka A, Maruyama I, Okada Y, Takashi K, Nukiwa T.

Pulm Med. 2011;2011:916486. doi: 10.1155/2011/916486. Epub 2011 Feb 21.

16.

Reevaluation of the efficacy and safety of the neutrophil elastase inhibitor, Sivelestat, for the treatment of acute lung injury associated with systemic inflammatory response syndrome; a phase IV study.

Aikawa N, Ishizaka A, Hirasawa H, Shimazaki S, Yamamoto Y, Sugimoto H, Shinozaki M, Taenaka N, Endo S, Ikeda T, Kawasaki Y.

Pulm Pharmacol Ther. 2011 Oct;24(5):549-54. doi: 10.1016/j.pupt.2011.03.001. Epub 2011 Apr 22.

PMID:
21540122
17.

Carbon black nanoparticles enhance bleomycin-induced lung inflammatory and fibrotic changes in mice.

Kamata H, Tasaka S, Inoue K, Miyamoto K, Nakano Y, Shinoda H, Kimizuka Y, Fujiwara H, Ishii M, Hasegawa N, Takamiya R, Fujishima S, Takano H, Ishizaka A.

Exp Biol Med (Maywood). 2011 Mar;236(3):315-24. doi: 10.1258/ebm.2011.010180.

PMID:
21427237
18.

Impact of serum high-mobility group box 1 protein elevation on oxygenation impairment after thoracic aortic aneurysm repair.

Kohno T, Anzai T, Shimizu H, Kaneko H, Sugano Y, Yamada S, Yoshikawa T, Ishizaka A, Yozu R, Ogawa S.

Heart Vessels. 2011 May;26(3):306-12. doi: 10.1007/s00380-010-0056-6. Epub 2010 Oct 30.

PMID:
21052685
19.

Distinct epigenetic regulation of tumor suppressor genes in putative cancer stem cells of solid tumors.

Yasuda H, Soejima K, Watanabe H, Kawada I, Nakachi I, Yoda S, Nakayama S, Satomi R, Ikemura S, Terai H, Sato T, Suzuki S, Matsuzaki Y, Naoki K, Ishizaka A.

Int J Oncol. 2010 Dec;37(6):1537-46.

PMID:
21042723
20.

Bronchoscopic microsampling is a useful complementary diagnostic tool for detecting lung cancer.

Yasuda H, Soejima K, Nakayama S, Kawada I, Nakachi I, Yoda S, Satomi R, Ikemura S, Terai H, Sato T, Watanabe H, Naoki K, Hayashi Y, Ishizaka A.

Lung Cancer. 2011 Apr;72(1):32-8. doi: 10.1016/j.lungcan.2010.07.016.

PMID:
20813423
21.

Evaluation of pathogen detection from clinical samples by real-time polymerase chain reaction using a sepsis pathogen DNA detection kit.

Yanagihara K, Kitagawa Y, Tomonaga M, Tsukasaki K, Kohno S, Seki M, Sugimoto H, Shimazu T, Tasaki O, Matsushima A, Ikeda Y, Okamoto S, Aikawa N, Hori S, Obara H, Ishizaka A, Hasegawa N, Takeda J, Kamihira S, Sugahara K, Asari S, Murata M, Kobayashi Y, Ginba H, Sumiyama Y, Kitajima M.

Crit Care. 2010;14(4):R159. doi: 10.1186/cc9234. Epub 2010 Aug 24.

22.

Production and activation of matrix metalloproteinase 7 (matrilysin 1) in the lungs of patients with idiopathic pulmonary fibrosis.

Fujishima S, Shiomi T, Yamashita S, Yogo Y, Nakano Y, Inoue T, Nakamura M, Tasaka S, Hasegawa N, Aikawa N, Ishizaka A, Okada Y.

Arch Pathol Lab Med. 2010 Aug;134(8):1136-42. doi: 10.1043/2009-0144-OA.1.

PMID:
20670133
23.

Role of interleukin-6 in elastase-induced lung inflammatory changes in mice.

Tasaka S, Inoue K, Miyamoto K, Nakano Y, Kamata H, Shinoda H, Hasegawa N, Miyasho T, Satoh M, Takano H, Ishizaka A.

Exp Lung Res. 2010 Aug;36(6):362-72. doi: 10.3109/01902141003678590.

PMID:
20653471
24.

The combination of multiple receptor tyrosine kinase inhibitor and mammalian target of rapamycin inhibitor overcomes erlotinib resistance in lung cancer cell lines through c-Met inhibition.

Nakachi I, Naoki K, Soejima K, Kawada I, Watanabe H, Yasuda H, Nakayama S, Yoda S, Satomi R, Ikemura S, Terai H, Sato T, Ishizaka A.

Mol Cancer Res. 2010 Aug;8(8):1142-51. doi: 10.1158/1541-7786.MCR-09-0388. Epub 2010 Jul 20.

25.

High-mobility-group box chromosomal protein 1 as a new target for modulating stress response.

Suda K, Takeuchi H, Ishizaka A, Kitagawa Y.

Surg Today. 2010 Jul;40(7):592-601. doi: 10.1007/s00595-009-4232-1. Epub 2010 Jun 26. Review.

PMID:
20582508
26.

Association between beta-adrenoceptor gene polymorphisms and relative response to beta 2-agonists and anticholinergic drugs in Japanese asthmatic patients.

Asano K, Yamada-Yamasawa W, Kudoh H, Matsuzaki T, Nakajima T, Hakuno H, Hiraoka R, Fukunaga K, Oguma T, Sayama K, Yamaguchi K, Nagabukuro A, Harada Y, Ishizaka A.

Respirology. 2010 Jul;15(5):849-54. doi: 10.1111/j.1440-1843.2010.01786.x. Epub 2010 Jun 9.

PMID:
20546196
27.

Strain-specific phenotypes of airway inflammation and bronchial hyperresponsiveness induced by epicutaneous allergen sensitization in BALB/c and C57BL/6 mice.

Kodama M, Asano K, Oguma T, Kagawa S, Tomomatsu K, Wakaki M, Takihara T, Ueda S, Ohmori N, Ogura H, Miyata J, Tanaka K, Kamiishi N, Fukunaga K, Sayama K, Ikeda E, Miyasho T, Ishizaka A.

Int Arch Allergy Immunol. 2010;152 Suppl 1:67-74. doi: 10.1159/000312128. Epub 2010 Jun 4.

PMID:
20523066
28.

Requiem protein links RelB/p52 and the Brm-type SWI/SNF complex in a noncanonical NF-kappaB pathway.

Tando T, Ishizaka A, Watanabe H, Ito T, Iida S, Haraguchi T, Mizutani T, Izumi T, Isobe T, Akiyama T, Inoue J, Iba H.

J Biol Chem. 2010 Jul 16;285(29):21951-60. doi: 10.1074/jbc.M109.087783. Epub 2010 May 11.

29.

Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis.

Collard HR, Calfee CS, Wolters PJ, Song JW, Hong SB, Brady S, Ishizaka A, Jones KD, King TE Jr, Matthay MA, Kim DS.

Am J Physiol Lung Cell Mol Physiol. 2010 Jul;299(1):L3-7. doi: 10.1152/ajplung.90637.2008. Epub 2010 Apr 23.

30.

[A case of miliary tuberculosis showing acute respiratory distress syndrome in rheumatoid arthritis].

Matsuzaki T, Terashima T, Ogawa R, Naitou A, Miyauchi J, Morishita T, Ishizaka A.

Nihon Kokyuki Gakkai Zasshi. 2010 Mar;48(3):235-9. Japanese.

PMID:
20387530
31.

Effect of Toll-like receptor 4 inhibitor on LPS-induced lung injury.

Seki H, Tasaka S, Fukunaga K, Shiraishi Y, Moriyama K, Miyamoto K, Nakano Y, Matsunaga N, Takashima K, Matsumoto T, Ii M, Ishizaka A, Takeda J.

Inflamm Res. 2010 Oct;59(10):837-45. doi: 10.1007/s00011-010-0195-3. Epub 2010 Apr 13.

PMID:
20387088
32.

Acute respiratory distress syndrome after percutaneous cryotherapy for a pulmonary metastatic lesion.

Tasaka S, Tomomatsu K, Funatsu Y, Soejima K, Ishizaka A.

Intern Med. 2010;49(5):431-3. Epub 2010 Mar 1.

33.

[Long-term treatment with a humanized anti-interleukin-6 receptor antibody (tocilizumab), improving interstitial pneumonia in a patient with multicentric Castleman disease].

Harada N, Sayama K, Tanaka K, Hasegawa N, Okamoto S, Hayashi Y, Ishizaka A.

Nihon Kokyuki Gakkai Zasshi. 2010 Feb;48(2):145-50. Japanese.

PMID:
20184247
34.

The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury.

Seki H, Fukunaga K, Arita M, Arai H, Nakanishi H, Taguchi R, Miyasho T, Takamiya R, Asano K, Ishizaka A, Takeda J, Levy BD.

J Immunol. 2010 Jan 15;184(2):836-43. doi: 10.4049/jimmunol.0901809. Epub 2009 Dec 9.

35.

[Effect of direct hemoperfusion with a polymyxin B immobilized fiber column in acute exacerbation of interstitial pneumonia and serum indicators].

Miyamoto K, Tasaka S, Hasegawa N, Kamata H, Shinoda H, Kimizuka Y, Fujiwara H, Kotake Y, Takeda J, Ishizaka A.

Nihon Kokyuki Gakkai Zasshi. 2009 Nov;47(11):978-84. Japanese.

PMID:
19994591
36.

Neutrophil elastase inhibitor improves survival of rats with clinically relevant sepsis.

Suda K, Takeuchi H, Hagiwara T, Miyasho T, Okamoto M, Kawasako K, Yamada S, Suganuma K, Wada N, Saikawa Y, Fukunaga K, Funakoshi Y, Hashimoto S, Yokota H, Maruyama I, Ishizaka A, Kitagawa Y.

Shock. 2010 May;33(5):526-31. doi: 10.1097/SHK.0b013e3181cc064b.

PMID:
19953005
37.

Laminin gamma2 fragments are increased in the circulation of patients with early phase acute lung injury.

Katayama M, Ishizaka A, Sakamoto M, Fujishima S, Sekiguchi K, Asano K, Betsuyaku T, Kotani T, Ware LB, Matthay MA, Hashimoto S.

Intensive Care Med. 2010 Mar;36(3):479-86. doi: 10.1007/s00134-009-1719-6. Epub 2009 Nov 26.

38.

Intratracheal synthetic CpG oligodeoxynucleotide causes acute lung injury with systemic inflammatory response.

Tasaka S, Kamata H, Miyamoto K, Nakano Y, Shinoda H, Kimizuka Y, Fujiwara H, Hasegawa N, Fujishima S, Miyasho T, Ishizaka A.

Respir Res. 2009 Sep 23;10:84. doi: 10.1186/1465-9921-10-84.

39.

[Appropriate hemodialysis scheduling based on therapeutic drug monitoring of carboplatin in a patient with lung cancer and chronic renal failure].

Kamata H, Asano K, Soejima K, Shirahata T, Nakatani M, Inamoto H, Iketani O, Yamayoshi Y, Tanigawara Y, Ishizaka A.

Gan To Kagaku Ryoho. 2009 Sep;36(9):1529-32. Japanese.

PMID:
19755826
40.

Converging stereotactic radiotherapy using kilovoltage X-rays: experimental irradiation of normal rabbit lung and dose-volume analysis with Monte Carlo simulation.

Kawase T, Kunieda E, Deloar HM, Tsunoo T, Seki S, Oku Y, Saitoh H, Saito K, Ogawa EN, Ishizaka A, Kameyama K, Kubo A.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):468-74. doi: 10.1016/j.ijrobp.2009.01.085.

PMID:
19735870
41.

Loss of the Brm-type SWI/SNF chromatin remodeling complex is a strong barrier to the Tat-independent transcriptional elongation of human immunodeficiency virus type 1 transcripts.

Mizutani T, Ishizaka A, Tomizawa M, Okazaki T, Yamamichi N, Kawana-Tachikawa A, Iwamoto A, Iba H.

J Virol. 2009 Nov;83(22):11569-80. doi: 10.1128/JVI.00742-09. Epub 2009 Sep 2.

42.

Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis.

Yogo Y, Fujishima S, Inoue T, Saito F, Shiomi T, Yamaguchi K, Ishizaka A.

Respir Res. 2009 Aug 29;10:80. doi: 10.1186/1465-9921-10-80.

43.

Impact of pharmacokinetics and pharmacogenetics on the efficacy of pranlukast in Japanese asthmatics.

Asano K, Nakade S, Shiomi T, Nakajima T, Suzuki Y, Fukunaga K, Oguma T, Sayama K, Fujita H, Tanigawara Y, Ishizaka A.

Respirology. 2009 Aug;14(6):822-7. doi: 10.1111/j.1440-1843.2009.01552.x.

PMID:
19703064
44.

Involvement of E-cadherin cleavage in reperfusion injury.

Goto T, Ishizaka A, Katayama M, Kohno M, Tasaka S, Fujishima S, Kobayashi K, Nomori H.

Eur J Cardiothorac Surg. 2010 Feb;37(2):426-31. doi: 10.1016/j.ejcts.2009.06.041. Epub 2009 Jul 29.

PMID:
19643628
45.

Elevated serum adiponectin level in patients with Mycobacterium avium-intracellulare complex pulmonary disease.

Tasaka S, Hasegawa N, Nishimura T, Yamasawa W, Kamata H, Shinoda H, Kimizuka Y, Fujiwara H, Hirose H, Ishizaka A.

Respiration. 2010;79(5):383-7. doi: 10.1159/000231975. Epub 2009 Jul 29.

46.

Gene expression analysis of endobronchial epithelial lining fluid in the evaluation of indeterminate pulmonary nodules.

Kahn N, Kuner R, Eberhardt R, Meister M, Muley T, Winteroll S, Schnabel PA, Ishizaka A, Herth FJ, Poustka A, Sültmann H, Hoffmann H.

J Thorac Cardiovasc Surg. 2009 Aug;138(2):474-9. doi: 10.1016/j.jtcvs.2009.04.024.

47.

Serodiagnostic contributions of antibody titers against mycobacterial lipid antigens in Mycobacterium avium complex pulmonary disease.

Nishimura T, Hasegawa N, Fujita Y, Yano I, Ishizaka A.

Clin Infect Dis. 2009 Aug 15;49(4):529-35. doi: 10.1086/600888.

PMID:
19591595
48.

Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease.

Hasegawa N, Nishimura T, Ohtani S, Takeshita K, Fukunaga K, Tasaka S, Urano T, Ishii K, Miyairi M, Ishizaka A.

Chest. 2009 Dec;136(6):1569-1575. doi: 10.1378/chest.08-2567. Epub 2009 Jun 19.

PMID:
19542259
49.

Comparison of the pharmacodynamics of biapenem in bronchial epithelial lining fluid in healthy volunteers given half-hour and three-hour intravenous infusions.

Kikuchi E, Kikuchi J, Nasuhara Y, Oizumi S, Ishizaka A, Nishimura M.

Antimicrob Agents Chemother. 2009 Jul;53(7):2799-803. doi: 10.1128/AAC.01578-08. Epub 2009 Apr 20.

50.

Cdx2 and the Brm-type SWI/SNF complex cooperatively regulate villin expression in gastrointestinal cells.

Yamamichi N, Inada K, Furukawa C, Sakurai K, Tando T, Ishizaka A, Haraguchi T, Mizutani T, Fujishiro M, Shimomura R, Oka M, Ichinose M, Tsutsumi Y, Omata M, Iba H.

Exp Cell Res. 2009 Jun 10;315(10):1779-89. doi: 10.1016/j.yexcr.2009.01.006. Epub 2009 Jan 22.

PMID:
19371634

Supplemental Content

Loading ...
Support Center